🇺🇸 FDA
Pipeline program

QR-010

PQ-010-001

Phase 2 small_molecule completed

Quick answer

QR-010 for Cystic Fibrosis is a Phase 2 program (small_molecule) at ProQR Therapeutics N.V. with 2 ClinicalTrials.gov record(s).

Program details

Company
ProQR Therapeutics N.V.
Indication
Cystic Fibrosis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials